Serveur d'exploration sur Pittsburgh

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
***** Acces problem to record *****\

Identifieur interne : 001F05 ( Pmc/Corpus ); précédent : 001F049; suivant : 001F060 ***** probable Xml problem with record *****

Links to Exploration step


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Maternal immunization</title>
<author>
<name sortKey="Moniz, Michelle H" sort="Moniz, Michelle H" uniqKey="Moniz M" first="Michelle H" last="Moniz">Michelle H. Moniz</name>
<affiliation>
<nlm:aff id="af0001">
<institution>Robert Wood Johnson Foundation Clinical Scholars® Program; Department of Obstetrics and Gynecology; Institute for Healthcare Policy and Innovation; University of Michigan</institution>
; Ann Arbor, MI
<country>USA</country>
</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Beigi, Richard H" sort="Beigi, Richard H" uniqKey="Beigi R" first="Richard H" last="Beigi">Richard H. Beigi</name>
<affiliation>
<nlm:aff id="af0002">
<institution>Department of Obstetrics; Gynecology and Reproductive Sciences; Magee-Womens Hospital of the University of Pittsburgh Medical Center</institution>
; Pittsburgh, PA
<country>USA</country>
</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">25483490</idno>
<idno type="pmc">4977442</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977442</idno>
<idno type="RBID">PMC:4977442</idno>
<idno type="doi">10.4161/21645515.2014.970901</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">001F05</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001F05</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Maternal immunization</title>
<author>
<name sortKey="Moniz, Michelle H" sort="Moniz, Michelle H" uniqKey="Moniz M" first="Michelle H" last="Moniz">Michelle H. Moniz</name>
<affiliation>
<nlm:aff id="af0001">
<institution>Robert Wood Johnson Foundation Clinical Scholars® Program; Department of Obstetrics and Gynecology; Institute for Healthcare Policy and Innovation; University of Michigan</institution>
; Ann Arbor, MI
<country>USA</country>
</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Beigi, Richard H" sort="Beigi, Richard H" uniqKey="Beigi R" first="Richard H" last="Beigi">Richard H. Beigi</name>
<affiliation>
<nlm:aff id="af0002">
<institution>Department of Obstetrics; Gynecology and Reproductive Sciences; Magee-Womens Hospital of the University of Pittsburgh Medical Center</institution>
; Pittsburgh, PA
<country>USA</country>
</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Human Vaccines & Immunotherapeutics</title>
<idno type="ISSN">2164-5515</idno>
<idno type="eISSN">2164-554X</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Maternal immunization holds tremendous promise to improve maternal and neonatal health for a number of infectious conditions. The unique susceptibilities of pregnant women to infectious conditions, as well as the ability of maternally-derived antibody to offer vital neonatal protection (via placental transfer), together have produced the recent increased attention on maternal immunization. The Advisory Committee on Immunization Practices (ACIP) currently recommends 2 immunizations for all pregnant women lacking contraindication, inactivated Influenza and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap). Given ongoing research the number of vaccines recommended during pregnancy is likely to increase. Thus, achieving high vaccination coverage of pregnant women for all recommended immunizations is a key public health enterprise. This review will focus on the present state of vaccine acceptance in pregnancy, with attention to currently identified barriers and determinants of vaccine acceptance. Additionally, opportunities for improvement will be considered.</p>
</div>
</front>
</TEI>
<pmc article-type="review-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Vaccin Immunother</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum Vaccin Immunother</journal-id>
<journal-id journal-id-type="publisher-id">KHVI</journal-id>
<journal-id journal-id-type="publisher-id">khvi20</journal-id>
<journal-title-group>
<journal-title>Human Vaccines & Immunotherapeutics</journal-title>
</journal-title-group>
<issn pub-type="ppub">2164-5515</issn>
<issn pub-type="epub">2164-554X</issn>
<publisher>
<publisher-name>Taylor & Francis</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">25483490</article-id>
<article-id pub-id-type="pmc">4977442</article-id>
<article-id pub-id-type="publisher-id">970901</article-id>
<article-id pub-id-type="doi">10.4161/21645515.2014.970901</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Maternal immunization</article-title>
<subtitle>Clinical experiences, challenges, and opportunities in vaccine acceptance</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Moniz</surname>
<given-names>Michelle H</given-names>
</name>
<xref ref-type="aff" rid="af0001">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="an0001">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Beigi</surname>
<given-names>Richard H</given-names>
</name>
<xref ref-type="aff" rid="af0002">
<sup>2</sup>
</xref>
</contrib>
<aff id="af0001">
<label>1</label>
<institution>Robert Wood Johnson Foundation Clinical Scholars® Program; Department of Obstetrics and Gynecology; Institute for Healthcare Policy and Innovation; University of Michigan</institution>
; Ann Arbor, MI
<country>USA</country>
</aff>
<aff id="af0002">
<label>2</label>
<institution>Department of Obstetrics; Gynecology and Reproductive Sciences; Magee-Womens Hospital of the University of Pittsburgh Medical Center</institution>
; Pittsburgh, PA
<country>USA</country>
</aff>
</contrib-group>
<author-notes>
<corresp id="an0001">
<label>*</label>
Correspondence to: Michelle H Moniz; Email:
<email xlink:href="mmoniz@med.umich.edu">mmoniz@med.umich.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="collection">
<month>9</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>10</month>
<year>2014</year>
</pub-date>
<volume>10</volume>
<issue>9</issue>
<fpage seq="10">2562</fpage>
<lpage>2570</lpage>
<history>
<date date-type="received">
<day>11</day>
<month>4</month>
<year>2014</year>
</date>
<date date-type="rev-recd">
<day>5</day>
<month>6</month>
<year>2014</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>6</month>
<year>2014</year>
</date>
</history>
<permissions>
<copyright-statement>© Taylor & Francis Group, LLC</copyright-statement>
<copyright-year>2014</copyright-year>
<copyright-holder>Taylor & Francis Group, LLC</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="khvi-10-09-970901.pdf"></self-uri>
<abstract>
<p>Maternal immunization holds tremendous promise to improve maternal and neonatal health for a number of infectious conditions. The unique susceptibilities of pregnant women to infectious conditions, as well as the ability of maternally-derived antibody to offer vital neonatal protection (via placental transfer), together have produced the recent increased attention on maternal immunization. The Advisory Committee on Immunization Practices (ACIP) currently recommends 2 immunizations for all pregnant women lacking contraindication, inactivated Influenza and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap). Given ongoing research the number of vaccines recommended during pregnancy is likely to increase. Thus, achieving high vaccination coverage of pregnant women for all recommended immunizations is a key public health enterprise. This review will focus on the present state of vaccine acceptance in pregnancy, with attention to currently identified barriers and determinants of vaccine acceptance. Additionally, opportunities for improvement will be considered.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>pregnancy</kwd>
<kwd>influenza</kwd>
<kwd>pertussis</kwd>
<kwd>vaccine</kwd>
<kwd>vaccination</kwd>
<kwd>immunization</kwd>
</kwd-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="2"></table-count>
<ref-count count="106"></ref-count>
<page-count count="9"></page-count>
</counts>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F05  | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 001F05  | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Amérique
   |area=    PittsburghV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     
   |texte=   
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021